{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:53:03Z","timestamp":1785815583337,"version":"3.56.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.urolonc.2021.05.016","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:35:00Z","timestamp":1625013300000},"page":"582-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers"],"prefix":"10.1016","volume":"39","author":[{"given":"Donna E.","family":"Hansel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0001","first-page":"125","article-title":"Classification of prostatic carcinomas","volume":"50","author":"Gleason","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.urolonc.2021.05.016_bib0002","unstructured":"WHO Classification of Tumours of the Urinary System and Male Genital Organs, WHO Classification of Tumours, 4th Edition, Volume 8, Edited by Moch H, Humphrey PA, Ulbright TM, Reuter VE 2016."},{"issue":"9","key":"10.1016\/j.urolonc.2021.05.016_bib0003","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","article-title":"The 2005 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma","volume":"29","author":"Epstein","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0004","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0005","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000478-200004000-00001","article-title":"Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made","volume":"24","author":"Epstein","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0006","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.016_bib0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1464-410X.2012.11611.x","article-title":"Prognostic Gleason grade grouping: data based on the modified Gleason scoring system","volume":"111","author":"Pierorazio","year":"2013","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0008","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.016_bib0009","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) consensus conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.05.016_bib0010","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.urolonc.2021.05.016_bib0011","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","article-title":"Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations","volume":"20","author":"McNeal","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0012","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/PAS.0000000000000208","article-title":"Proposed morphologic classification of prostate cancer with neuroendocrine differentiation","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"S1","key":"10.1016\/j.urolonc.2021.05.016_bib0013","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/modpathol.2017.164","article-title":"Neuroendocrine tumors of the prostate","volume":"31","author":"Fine","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0014","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/modpathol.2010.156","article-title":"International Society of Urological Pathology (ISUP) Consensus conference on handling and staging of radical prostatectomy specimens. Working group 2: T2 substaging and prostate cancer volume","volume":"24","author":"van der Kwast","year":"2011","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/modpathol.2010.178","article-title":"International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 1: specimen handling","volume":"24","author":"Samaratunga","year":"2011","journal-title":"Mod Pathol."},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0016","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.urology.2010.10.059","article-title":"Ability of linear length of positive margin in radical prostatectomy specimens to predict biochemical recurrence","volume":"77","author":"Cao","year":"2011","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.urolonc.2021.05.016_bib0017","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/PAS.0b013e3181e103bf","article-title":"The Gleason score of tumor at the margin in radical prostatectomy is predictive of biochemical recurrence","volume":"34","author":"Cao","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0019","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/bju.14812","article-title":"Multiparametric MRI prior to radical prostatectomy identifies intraductal and cribriform growth patterns in prostate cancer","volume":"124","author":"Tonttila","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.juro.2018.01.081","article-title":"Role of magnetic resonance imaging targed biopsy in detection of prostate cancer harboring adverse pathological features of intraductal carcinoma and invasive cribriform carcinoma","volume":"200","author":"Toi","year":"2018","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0022","first-page":"1011","article-title":"The Cancer Genome Atlas Research Network","volume":"163","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0023","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.2009.193","article-title":"Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort","volume":"23","author":"Esgueva","year":"2010","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0024","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00000478-200001000-00035","article-title":"Revised classification of urothelial neoplasms","volume":"24","author":"Harnden","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.05.016_bib0025","series-title":"Histological typing of urinary bladder tumours \/F. K. Mostofi, in collaboration with L. H. Sobin, H. Torloni and pathologists in fourteen countries","author":"Mostofi","year":"1973"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0026","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0090-4295(02)01705-3","article-title":"Comparison of WHO\/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression","volume":"60","author":"Samaratunga","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2021.05.016_bib0027","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1038\/modpathol.2008.235","article-title":"The current classification of urothelial neoplasms","volume":"22","author":"Grignon","year":"2009","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.05.016_bib0028","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00000478-199412000-00005","article-title":"Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma","volume":"18","author":"Amin","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0029","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/41VLTFX3YPP1HF6F","article-title":"HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases","volume":"130","author":"Hansel","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"3 Pt 1","key":"10.1016\/j.urolonc.2021.05.016_bib0030","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-5347(05)00423-4","article-title":"The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma","volume":"175","author":"Kamat","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0031","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ng.3503","article-title":"Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer","volume":"48","author":"Al-Ahmadie","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0032","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/s41379-020-0453-z","article-title":"PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates","volume":"33","author":"Taylor","year":"2020","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.05.016_bib0033","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1097\/PAS.0b013e31805c9cd9","article-title":"Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases","volume":"31","author":"Lagwinski","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.016_bib0034","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/PAS.0000000000000250","article-title":"Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification","volume":"38","author":"Amin","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/PAT.0000000000000301","article-title":"High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma","volume":"47","author":"Gupta","year":"2015","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0036","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1200\/JCO.2014.57.6967","article-title":"Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients","volume":"33","author":"Martin-Doyle","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0037","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anndiagpath.2013.11.002","article-title":"Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence","volume":"18","author":"Hu","year":"2014","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0038","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"van Rhijn","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0039","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","article-title":"Analysis of T1 bladder cancer on biopsy and transurethral resection specimens: comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion","volume":"42","author":"Leivo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2021.05.016_bib0040","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2018"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0041","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2006.03.065","article-title":"Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cytectomy","volume":"176","author":"Yu","year":"2006","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0042","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.juro.2012.09.006","article-title":"Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma","volume":"189","author":"Patel","year":"2013","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0043","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.juro.2013.10.142","article-title":"Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate","volume":"191","author":"Lavery","year":"2014","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0044","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.juro.2010.04.081","article-title":"Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients","volume":"184","author":"Tilki","year":"2010","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/his.12360","article-title":"Uroplakin II outperforms uroplakin III in diagnostically challenging settings","volume":"65","author":"Smith","year":"2014","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.016_bib0046","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e318260cde7","article-title":"Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0047","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7492","key":"10.1016\/j.urolonc.2021.05.016_bib0048","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0049","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0050","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","article-title":"Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy","volume":"25","author":"Choi","year":"2014","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.016_bib0051","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/1878-0261.12325","article-title":"Molecular subtype classification of urothelial carcinoma in Lynch syndrome","volume":"12","author":"Therkildsen","year":"2018","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0052","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.juro.2017.08.002","article-title":"Universal point of care testing for lynch syndrome in patients with upper tract urothelial carcinoma","volume":"199","author":"Metcalfe","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0053","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAP.0000000000000118","article-title":"The Paris System for reporting urinary cytology: the quest to develop a standardized terminology","volume":"23","author":"Barkan","year":"2016","journal-title":"Adv Anat Pathol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.05.016_bib0054","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/PAS.0000000000001569","article-title":"Primary female urethral carcinoma: proposed staging modifications based on assessment of female urethral histology and analysis of a large series of female urethral carcinomas","volume":"44","author":"Aron","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"14","key":"10.1016\/j.urolonc.2021.05.016_bib0055","first-page":"2827","article-title":"Identification of the MN\/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney","volume":"57","author":"Liao","year":"1997","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0056","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/00313020310001619901","article-title":"Distinctive neoplasms characterized by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas","volume":"35","author":"Argani","year":"2003","journal-title":"Pathology"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0057","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","article-title":"Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents","volume":"159","author":"Argani","year":"2001","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.016_bib0058","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1073\/pnas.0931430100","article-title":"Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation","volume":"100","author":"Davis","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.urolonc.2021.05.016_bib0059","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/PAS.0b013e318164bcbb","article-title":"Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity","volume":"32","author":"Gobbo","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/modpathol.2014.86","article-title":"Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma","volume":"28","author":"Williamson","year":"2015","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.05.016_bib0061","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.05.016_bib0062","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2559.2002.01515.x","article-title":"Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report of 11 cases including a case with hybrid conventional renal cell carcinoma\/spindle and cuboidal renal cell carcinoma components","volume":"41","author":"Hes","year":"2002","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.016_bib0063","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/hupa.2001.24320","article-title":"Low-grade myxoid renal epithelial neoplasms with distal nephron differentiation","volume":"32","author":"Parwani","year":"2001","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0064","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAS.0b013e3181872d3f","article-title":"Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma","volume":"33","author":"Amin","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.pas.0000185382.80844.b1","article-title":"Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia","volume":"30","author":"Tickoo","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.016_bib0066","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.humpath.2015.07.001","article-title":"Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome","volume":"46","author":"Cornejo","year":"2015","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0067","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-08-1229","article-title":"Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma","volume":"15","author":"Klatte","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0068","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0069","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","article-title":"Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome","volume":"37","author":"Sanz-Ortega","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.016_bib0070","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.05.016_bib0071","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/PAS.0b013e318299f0fb","article-title":"The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters","volume":"37","author":"Delahunt","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"22","key":"10.1016\/j.urolonc.2021.05.016_bib0072","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/jnci\/87.22.1705","article-title":"Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma","volume":"87","author":"Gregoire","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0073","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","article-title":"Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis","volume":"159","author":"Rubin","year":"2001","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.016_bib0074","first-page":"2513","article-title":"The role of human papilloma virus in urological malignancies","volume":"35","author":"Heidegger","year":"2015","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrc1568","article-title":"Testicular germ-cell tumours in a broader perspective","volume":"5","author":"Oosterhuis","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0076","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/path.1587","article-title":"Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells","volume":"203","author":"Honecker","year":"2004","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.urolonc.2021.05.016_bib0077","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/PAS.0000000000001465","article-title":"Report From the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: IV: current and future utilization of molecular-genetic tests for testicular germ cell tumors","volume":"44","author":"Looijenga","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0078","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/humupd\/dmk006","article-title":"Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects","volume":"12","author":"Rajpert-De Meyts","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"4","key":"10.1016\/j.urolonc.2021.05.016_bib0079","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.eururo.2014.07.011","article-title":"Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model","volume":"67","author":"van der Zwan","year":"2015","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/cancers12030749","article-title":"Non-coding microRNAs as novel potential tumor markers in testicular cancer","volume":"12","author":"Regouc","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"16","key":"10.1016\/j.urolonc.2021.05.016_bib0081","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1200\/JCO.18.01480","article-title":"Serum levels of microRNA-371a-3p (M371 test) as a new biomarkers of testicular germ cell tumors: results of a prospective multicentric study","volume":"37","author":"Dieckmann","year":"2019","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.016_bib0082","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/PAP.0000000000000120","article-title":"Adrenal Pathology in the Adult: A Urological Pathologist's Perspective","volume":"23","author":"Hansel","year":"2016","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.05.016_bib0083","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.urolonc.2021.05.016_bib0084","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/00000478-200212000-00009","article-title":"Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors","volume":"26","author":"Aubert","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.016_bib0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.05.016_bib0086","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.urolonc.2021.05.016_bib0087","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive Pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0088","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.urolonc.2021.05.016_bib0089","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1756287217742564","article-title":"Circulating tumor cells in genitourinary tumors","volume":"10","author":"Massari","year":"2018","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.urolonc.2021.05.016_bib0090","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41379-020-0551-y","article-title":"Novel artifical intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies","volume":"33","author":"Raciti","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.urolonc.2021.05.016_bib0091","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/s41379-020-0601-5","article-title":"Validation of a digital pathology system including remote review during the COVID-19 pandemic","volume":"33","author":"Hanna","year":"2020","journal-title":"Mod Pathol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921002222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:22:48Z","timestamp":1761042168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921002222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":91,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1078143921002222"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}